Company Description
Guardian Pharmacy Services is a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of long-term health care facilities (“LTCFs”) adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes.
We emphasize high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as assisted living facilities (“ALFs”), and behavioral health facilities and group homes (collectively “BHFs”).
More than two-thirds of our annual revenue for each of the past three years has been generated from residents of ALFs and BHFs, which are our target markets, while the remainder has been generated primarily from residents of skilled nursing facilities (“SNFs”).
Additionally, our robust capabilities enable us to serve residents in all types of LTCFs. We are a trusted partner to residents, LTCFs and health plan payors because we help reduce errors in drug administration, manage and ensure adherence to drug regimens, and lower overall healthcare costs.
As of June 30, 2023, our 43 pharmacies served approximately 156,000 residents in approximately 5,800 LTCFs across 28 states.
| Country | United States |
| Founded | 2004 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Employees | 2,900 |
| CEO | Fred P. Burke |
Contact Details
Address: 300 Galleria Parkway SE, Suite 800 Atlanta, GA 30339 United States | |
| Phone | (404) 810-0089 |
| Website | guardianpharmacy.com |
Stock Details
| Ticker Symbol | GRDN |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001802255 |
| Employer ID | 20-0100834 |
| SIC Code | 5912 |
Key Executives
| Name | Position |
|---|---|
| Fred Burke | President and Chief Executive Officer |
| David Morris | Executive Vice President and Chief Financial Officer |
| Kendall Forbes | Executive Vice President of Sales & Operations |
| William Bindley | Chairman of the Board of Directors |
| John Ackerman | Class II Director |
| Steve Cosler | Class III Director |
| Randall Lewis | Class II Director |
| Mary Sue Patchett | Class I Director |
| Thomas Salentine, Jr. | Class I Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 3, 2023 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Aug 23, 2023 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jul 12, 2023 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| May 12, 2023 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Nov 22, 2021 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jul 23, 2021 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Apr 3, 2020 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Feb 13, 2020 | DRS | [Cover] Draft Registration Statement |